RaySearch Laboratories

Report Publication Announcement • Apr 26, 2023

PRESS RELEASE STOCKHOLM, APRIL 26, 2023

RaySearch publishes the annual report for 2022 on April 28

RaySearch Laboratories AB (publ) announces that the date for publication of the annual report for 2022 will be April 28. The previously communicated date was April 27.

Due to previously announced preliminary figures and breach of covenants, an update of the annual report is required, whereby the publication takes place one day later than previously communicated.

About RaySearch

RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.

RaySearch software has been sold to over 900 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.

* Subject to regulatory clearance in some markets.

For more information, please contact: Johan Löf, founder and CEO, RaySearch Laboratories AB (publ) Telephone: +46 (0) 8 510 530 00 johan.lof@raysearchlabs.com

Henrik Bergentoft, CFO, RaySearch Laboratories AB (publ) Telephone: +46 (0) 8 510 530 00 henrik.bergentoft@raysearchlabs.com